Oracle Partners with Wipro to Strengthen End-to-End Pharmacovigilance Services

Oracle and Wipro will offer cloud-based, deployment-ready pharmacovigilance services to help life sciences organizations modernize drug safety and compliance operations.

Rhea-AI Summary

Oracle (ORCL) is partnering with Wipro to enhance Wipro’s pharmacovigilance service offerings using Oracle Life Sciences Argus business process services (BPS), as of September 22, 2026.

The collaboration aims to help life sciences organizations modernize drug safety operations, with faster onboarding, streamlined safety workflows, and built-in regulatory compliance support across the drug safety lifecycle. Oracle Life Sciences Argus BPS provides a cloud-based, managed services model for scalable pharmacovigilance, while Wipro integrates it into its Wipro Intelligence suite to offer deployment-ready safety services. Wipro’s PV services cover case processing, reporting, regulatory submissions, QPPV support, and post-marketing surveillance, supported by preconfigured Argus BPS environments for quicker implementation.

Argus 15 min delay

+1.98% vs previous close $151.50 last price 1.7x rel. volume Open Argus

Details

Market Reaction – ORCL

$148.10 $151.70 Day Range

$458.10B Market Cap

Following this news, ORCL has gained 1.98%, reflecting a mild positive market reaction. The stock is currently trading at $151.50. Trading volume is above average at 1.7x the average, suggesting increased trading activity.

Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.

Market Context

Pre-headline, ORCL was up 0.64%; four of five listed peers were also higher, led by FFIV at 3.95%. T...

Analysis

Pre-headline, ORCL was up 0.64%; four of five listed peers were also higher, led by FFIV at 3.95%. This aligned market context accompanied the partnership announcement rather than indicating an isolated target move.

Key Terms

pharmacovigilance, qppv

2 terms

pharmacovigilance medical

"strengthen Wipro's pharmacovigilance (PV) service offering"

Pharmacovigilance is the process of monitoring and assessing the safety of medicines after they are on the market, ensuring that any side effects or risks are identified and managed. For investors, it matters because it helps ensure that pharmaceutical companies maintain safe products, which can influence a company’s reputation, regulatory approval, and financial stability over time.

qppv regulatory

"Qualified Person for Pharmacovigilance (QPPV) support"

Qualified Person for Pharmacovigilance (QPPV) is a legally required, named individual responsible for overseeing a drug maker’s global safety system and ensuring compliance with laws on monitoring and reporting adverse effects. The QPPV maintains safety databases, coordinates risk‑management and periodic safety reports, and acts as the regulatory contact for health authorities. Think of the QPPV as the company’s chief safety steward; their role matters to investors because lapses can lead to regulatory actions, delays, or reputational harm.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Collaboration to help life sciences organizations accelerate pharmacovigilance deployment with built-in compliance support

AUSTIN, Texas, Sept. 22, 2026 /PRNewswire/ -- Oracle Life Sciences announced a partnership with Wipro Limited, a leading AI-powered technology services and consulting company to strengthen Wipro's pharmacovigilance (PV) service offering using Oracle Life Sciences Argus business process services (BPS). With Argus, Wipro will enhance drug safety operations and compliance support for life sciences organisations globally, enabling faster onboarding, streamlined safety workflows, and support for the regulatory compliance process across the drug safety lifecycle.

"Life sciences organizations are under increasing pressure to modernize safety operations while maintaining compliance and speed," said Jasjit Singh Kang, Managing Partner & Global Head of Business Process Services, Wipro Limited. "By integrating Oracle Life Sciences Argus BPS into our Wipro Intelligence™ suite of AI-powered solutions, Wipro's PV service offerings can be enhanced to offer customers scalable, ready-to-deploy safety services."

Oracle Argus BPS provides the foundation for scalable, cloud-based pharmacovigilance services
Oracle Life Sciences Argus is a leading pharmacovigilance solution that helps organizations manage drug safety data, automate workflows, support regulatory reporting, and provide visibility across safety operations. Oracle Life Sciences Argus BPS extends that foundation into a cloud-based, managed services model, providing flexible infrastructure, and built-in compliance capabilities. The cloud-based managed services model enables organizations like Wipro to deliver scalable pharmacovigilance (PV) services without the burden of maintaining on-premises safety systems.

Wipro's PV services span case processing, reporting, regulatory submissions, Qualified Person for Pharmacovigilance (QPPV) support, and post-marketing surveillance.

To help customers accelerate results, Wipro is adopting a go-to-market model in which preconfigured Oracle Life Sciences Argus BPS environments are maintained and deployment-ready prior to customer onboarding. This approach can help streamline implementation timelines and accelerate the delivery of PV operations once deployment begins.

"Our collaboration with Wipro reflects the growing demand for comprehensive, cloud-based pharmacovigilance solutions that help life sciences organizations modernize safety operations and accelerate drug development," said Seema Verma, executive vice president and general manager, Oracle Health and Life Sciences. "Together, we are supporting a more agile and deployment-ready approach to pharmacovigilance by combining Oracle's proven safety platform with Wipro's deep domain and services expertise and commitment to advancing life sciences innovation."

Learn about how customers, partners, and CROs are using Oracle's unified life sciences platform to streamline drug safety operations, accelerate PV service delivery, and support regulatory compliance across the full drug lifecycle from clinical development through post-marketing surveillance at www.oracle.com/lifesciences.

About Oracle Life Sciences
Oracle Life Sciences is a leader in cloud technology, pharmaceutical research, and consulting, trusted globally by professionals in both large and emerging companies engaged in clinical research and pharmacovigilance, throughout the therapeutic development lifecycle, including pre- and post-drug launch activities. With more than 20 years of experience, Oracle Life Sciences is committed to supporting clinical development and leveraging real-world evidence to deliver innovation and accelerate advancements—empowering the life sciences industry to improve patient outcomes. Learn more at www.oracle.com/lifesciences.

About Oracle
Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE: ORCL), please visit us at www.oracle.com.

Trademarks
Oracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company—ushering in the new era of cloud computing.

View original content to download multimedia:https://www.prnewswire.com/news-releases/oracle-partners-with-wipro-to-strengthen-end-to-end-pharmacovigilance-services-302883750.html

SOURCE Oracle

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is Oracle Life Sciences Argus BPS and how does it support pharmacovigilance services?

Oracle Life Sciences Argus is a pharmacovigilance solution that helps manage drug safety data, automate workflows, support regulatory reporting, and provide visibility across safety operations. Argus BPS extends this into a cloud-based, managed services model with flexible infrastructure and built-in compliance capabilities, enabling organizations to deliver scalable pharmacovigilance services without maintaining on-premises safety systems.

How will Wipro use Oracle Life Sciences Argus BPS in its pharmacovigilance offerings?

Wipro is integrating Oracle Life Sciences Argus BPS into its Wipro Intelligence suite of AI-powered solutions to enhance its pharmacovigilance services. The company will maintain preconfigured, deployment-ready Argus BPS environments before customer onboarding to help streamline implementation timelines and accelerate the delivery of PV operations.

What specific pharmacovigilance services does Wipro provide under this collaboration?

Wipro’s pharmacovigilance services span case processing, reporting, regulatory submissions, Qualified Person for Pharmacovigilance (QPPV) support, and post-marketing surveillance, delivered using the cloud-based Oracle Life Sciences Argus BPS platform.